New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 23, 2014
09:23 EDTNFLX, CIE, SILC, PCP, ZHNE, VLO, PSTI, INO, LLY, AEO, UNP, ARIA, LMT, MCD, LUV, UAL, EBAY, LOGIOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Netflix (NFLX), up 17%... Southwest Airlines (LUV), up 2.3%... Union Pacific (UNP), up 2%... Silicom (SILC), up 31%... Logitech (LOGI), up 16%... Lockheed Martin (LMT), up 1%... ALSO HIGHER: eBay (EBAY), up 2% after reporting earnings and guidance and also announcing it received a proposal from Carl Icahn regarding a spin-off of its PayPal unit... ARIAD (ARIA), up 10.6% after Daily Mail said Eli Lilly (LLY) approached the company about a possible deal... Inovio (INO), up 6.5% after announcing new immune activator... Pluristemae (PSTI), up 2.6% after receiving PEI approval for scaled-up 3D manufacturing... Valero (VLO), up 3% after giving Q4 guidance... Cobalt (CIE), up 4.6% after announcing first syn-rift discovery in deepwater Angola. DOWN AFTER EARNINGS: United Continental (UAL), up 2.9%... McDonald's (MCD), down 0.2%... Zhone (ZHNE), down 20%... Precision Castparts (PCP), down 2.5%. ALSO LOWER: American Eagle (AEO), down 6.4% after the company announced CEO Robert Hanson is leaving the company, to be replaced in interim by Jay Schottenstein.
News For NFLX;EBAY;UAL;LUV;MCD;LMT;ARIA;UNP;AEO;LLY;INO;PSTI;VLO;ZHNE;PCP;SILC;CIE;LOGI From The Last 14 Days
Check below for free stories on NFLX;EBAY;UAL;LUV;MCD;LMT;ARIA;UNP;AEO;LLY;INO;PSTI;VLO;ZHNE;PCP;SILC;CIE;LOGI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>
September 9, 2014
08:22 EDTNFLXNetflix price target raised to $600 from $530 at RBC Capital
Subscribe for More Information
08:00 EDTMCDMcDonald's: China supplier issue to negatively impact Q3 by 15c-20c
This is largely due to a combination of lost sales, expenses associated with our recovery efforts and the impact of these items on the third quarter tax rate, which is expected to be above the company's outlook for the full-year tax rate of 31-33%.
07:59 EDTMCDMcDonald's CEO: McDonald's global business faced several headwinds
Subscribe for More Information
07:58 EDTMCDMcDonald's reports August global comparable sales down 3.7%
Subscribe for More Information
07:31 EDTNFLXNetflix enters online U.S. net neutrality strike, Reuters says
Subscribe for More Information
06:22 EDTEBAYPayPal may let merchants accept bitcoin, FT reports
Subscribe for More Information
05:40 EDTUAL, LUVU.S. Airline sector initiated with an Overweight at Credit Suisse
Subscribe for More Information
05:33 EDTUALUnited Continental initiated with an Outperform at Credit Suisse
Subscribe for More Information
September 8, 2014
17:18 EDTUALUnited Continental reports August consolidated traffic up 0.1% vs. last year
Subscribe for More Information
16:02 EDTUALUnited Continental initiated with an Outperform at Credit Suisse
Subscribe for More Information
16:02 EDTLUVSouthwest initiated with a Neutral at Credit Suisse
Subscribe for More Information
16:00 EDTNFLXOptions Update; September 8, 2014
Subscribe for More Information
12:47 EDTEBAYeBay's Braintree unit to let customers accept bitcoin, Re/code reports
Subscribe for More Information
11:37 EDTUALStocks with call strike movement; UAL AAL
Subscribe for More Information
09:40 EDTMCD, NFLXActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL TWTR TSLA YHOO BAC FB MSFT NFLX GILD MCD
08:21 EDTEBAYeBay marketplace trends could put estimates at risk, says RW Baird
Subscribe for More Information
07:42 EDTNFLXNetflix expands in Europe amid scrutiny, skepticism, WSJ says
Subscribe for More Information
07:15 EDTLLYIBC Life Sciences to hold a conference
10th Annual Cell Line Development & Engineering Conference to be held in Berkeley, California on September 8-10.
07:01 EDTLLYIgnyta names Robert Wild as Chief Scientific Officer
Subscribe for More Information
05:43 EDTPSTIPluristem Therapeutics advances to second cohort in PLX-PAD cells Phase I trial
Pluristem Therapeutics announced that its licensee, United Therapeutics Corporation, has completed the dosing of the first cohort of patients in its Phase I study using Pluristem's PLacental eXpanded, or PLX-PAD, cells in patients diagnosed with pulmonary arterial hypertension, or PAH. PAH, with a global market estimated at approximately $3B, is characterized by abnormally high blood pressure in the arteries of the lungs; it can disrupt lung and heart function, leading to debilitating conditions such as heart failure. The Phase I study, being conducted in Australia, is an open-label, dose-escalation study designed to enroll 9 patients diagnosed with PAH. The first cohort of 3 patients has received 0.5M PLX cells per kilogram body weight. An independent Data Safety Monitoring Board recommended advancement to the second cohort. The second cohort will receive 1M cells per kilogram, while the third cohort is planned to be administered 2M cells per kilogram. The primary endpoint of the study is the safety of PLX-PAD cells, which will be evaluated at 12 weeks and one year after dosing. Secondary efficacy endpoints are to be measured at six weeks post-treatment in order to assess changes in the ability to exercise, disease severity and cardio-respiratory function; measures include six-minute walk distance and cardio-pulmonary hemodynamic parameters evaluated via right heart catheterization and echocardiogram.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use